Abstract
Glioblastoma multiforme (GBM), a malignant astrocytic tumour, represents the most frequent tumour of the human brain. Nevertheless, its molecular pathology is not well understood. We utilized the immune system, which contributes to cancer protection, to help identify new GBM-related genes. By screening a human GBM cDNA library with autologous patient serum (SEREX-approach), we isolated a gene termed PHF3 (PHD finger protein 3). The gene product of PHF3 is immunogenic in GBM as tested in an allogenic patient serum screening demonstrating antibodies in 24 of 39 (61.53%) sera, whereas none of the 14 healthy persons had antibodies against PHF3. While previous SEREX studies revealed allogenic antibody responses up to 40%, our results for PHF3 represent the highest reported rate for a specific antibody response. We show that GBM patients with an antibody response against PHF3 show significant better survival than patients without PHF3-specific antibodies. Because the amino acid sequence of PHF3 contains a PHD finger (also termed LAP motif), a TFIIS homology, a proline rich region and nuclear localization signals, it supposedly functions as a transcription factor. A polyclonal antibody generated against PHF3 shows nuclear expression in most investigated formalin-fixed, paraffin embedded tissues. In GBM, PHF3 expression is concentrated in cells surrounding necroses.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aasland R, Gibbons TJ, Stewart AF . 1995 Trend. Biochem. Sci. 20: 56–59
Biernat W, Tohma Y, Yonekawa Y, Kleihues P, Ohgaki H . 1997 Acta Neuropathol. 94: 303–309
Blaes F, Klotz M, Huwer H, Straub U, Kalweit G, Schimrigk K, Schafers HJ . 2000 Ann. Thorac. Surg. 69: 254–258
Boon T, van der Bruggen P . 1996 J. Exp. Med. 183: 725–729
Coulson M, Robert S, Eyre HJ, Saint R . 1998 Genomics 48: 381–383
Chinot O, Martin PM . 1996 Biologie des tumeurs cérébrales gliales. Artem et Editions espaces 34, Montpellier
Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P . 1988 Cancer 62: 2152–2165
Dietrich P-Y, Walker PR, Saas P, de Tribolet N . 1997 Ann. NY Acad. Sci. 17: 124–140
Foley EJ . 1953 Cancer Res. 13: 835–837
Gibbons RJ, Picketts DJ, Villard L, Higgs DR . 1995 Cell 80: 837–845
Gilboa E . 1999 Immunity, Sept 260–270
Güre AO, Stockert E, Scanlan MJ, Keresztes RS, Jäger D, Altorki NK, Old LJ, Chen YT . 2000 Proc. Natl. Acad. Sci. 11: 4198–4203
Hampton TA, Conry RM, Khazaeli MB, Shaw DR, Curiel DT, LoBuglio AF, Strong TV . 2000 Cancer Gene Ther. 7: 446–455
Harlow E, Lane D . 1998 Antibodies. A Laboratory Manual Cold Spring Harbour Laboratory: USA
Hasenpusch-Theil K, Chadwick BP, Heath SK, Wilkinson DG, Feischauf AM . 1999 Mamm. Genome 10: 294–298
Heckel D, Brass N, Fischer U, Blin N, Steudel I, Fackler O, Zang KD, Meese E . 1997 Hum. Mol. Genet. 6: 2031–2041
Jung V, Romeike BFM, Henn W, Feiden W, Moringlane JR, Zang KD, Urbschat S . 1999 J. Neuropath. Exp. Neurol. 58: 993–999
Kleihues P, Burger PC . 2000 Glioblastoma. In: Tumours of the Nervous System IARC Press: Lyon pp. 29–39
Kornblith PL, Coakham HB, Pollock LA, Wood WC, Green SB, Smith BH . 1983 Cancer 52: 2230–2235
Merrifield RB . 1963 J. Am. Chem. Soc. 85: 2149–2158
Old LJ . 1981 Cancer Res. 41: 361–375
Prehn RT, Main JM . 1957 J. Natl. Cancer Inst. 18: 769–778
Rainov NG, Doberstein K-U, Fittkau M, Bahn H, Holzhausen HJ, Gantchev I, Burkert W . 1995 Clin. Cancer Res. 1: 775–781
Robinson C, Callow M, Stevenson S, Scott B, Robinson BWS, Lake RA . 2000 Am. J. Respir. Cell Mol. Biol. 22: 550–556
Saha V, Chaplin T, Gregorini A, Ayton P, Young BD . 1995 Proc. Natl. Acad. Sci. 92: 9737–9741
Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M . 1995 Proc. Natl. Acad. Sci. USA 92: 11810–11813
Scanlan MJ, Gordan JD, Willaimson B, Stockert E, Bander NH, Jongeneel V, Gure AO, Jäger D, Jäger E, Knuth A, Chen YT, Old LJ . 1999 Int. J. Cancer 83: 456–464
Scarcella DL, Chow CW, Gonzales MF, Economou C, Brassew F, Ashley DM . 1999 Clin. Cancer Res. 5: 335–341
Schlichtholz B, Legros Y, Gillet D, Gaillard C, Marty M, Lane D, Calvo F, Soussi T . 1992 Cancer Res. 52: 6380–6384
Shrikant P, Benveniste EN . 1996 J. Immunol. 157: 1819–1822
Soussi T . 2000 Cancer Res. 60: 1777–1788
Suresh MZ . 1996 Anticancer Res. 16: 2273–2278
Tureci O, Sahin U, Pfreundschuh M . 1997 Mol. Med. Today 3: 342–349
Van den Bruggen P, Traversari C, Chomez P, Chomez P, Lurquin C, de Plaen E, van den Eyde B, Knuth A, Boon T . 1991 Science 254: 1643–1647
Weller RO, Kida S, Zhang ET . 1992 Brain Pathol. 2: 277–284
Zinkernagel RM, Ehl S, Aichele P, Oehen S, Kündig T, Hengartner H . 1997 Immunol. Rev. 156: 199–209
Zuber J, Tchernitsa OI, Hinzmann B, Schmitz AC, Grips M, Hellriegel M, Sers C, Rosenthal A, Schäfer R . 2000 Nature Genet. 24: 144–152
Acknowledgements
We thank B Glass and G Bleymehl for critical reading this article. This work was kindly supported by a grant from the Deutsche Forschungsgemeinschaft, SFB 399 project A1. A-K Struss was a recipient of a grant from the Graduiertenkolleg ‘Zelluläre Regulation und Wachstum', Deutsche Forschungsgemeinschaft.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Struss, AK., Romeike, B., Munnia, A. et al. PHF3-specific antibody responses in over 60% of patients with glioblastoma multiforme. Oncogene 20, 4107–4114 (2001). https://doi.org/10.1038/sj.onc.1204552
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204552
Keywords
This article is cited by
-
Evolutionary diversification of the BetaM interactome acquired through co-option of the ATP1B4 gene in placental mammals
Scientific Reports (2016)
-
Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas
Journal of Experimental & Clinical Cancer Research (2012)
-
The identification of human tumour antigens: current status and future developments
Cancer Immunology, Immunotherapy (2006)
-
SPOC: A widely distributed domain associated with cancer, apoptosis and transcription
BMC Bioinformatics (2004)
-
Identification of a human glioma antigen, SOX6, recognized by patients' sera
Oncogene (2004)